Publicaciones (104) Publicaciones en las que ha participado algún/a investigador/a

2011

  1. A combined preclinical therapy of cannabinoids and temozolomide against glioma

    Molecular Cancer Therapeutics, Vol. 10, Núm. 1, pp. 90-103

  2. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke

    Stroke, Vol. 42, Núm. 1, pp. 196-203

  3. A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

    Breast Cancer Research, Vol. 13, Núm. 6

  4. A rigid lanthanide binding tag for NMR structural analysis of carbohydrates

    Chemical Communications, Vol. 47, Núm. 25, pp. 7179-7181

  5. Al final, el principio

    MoleQla: revista de Ciencias de la Universidad Pablo de Olavide, Núm. 4, pp. 37-40

  6. Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis

    Neurodegenerative Diseases, Vol. 8, Núm. 5, pp. 386-396

  7. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: Role of AMPK-dependent activation of autophagy

    Cell Death and Differentiation, Vol. 18, Núm. 7, pp. 1099-1111

  8. Association between adiposity indices and cardiometabolic risk factors among adults living in Puerto Rico

    Public Health Nutrition, Vol. 14, Núm. 10, pp. 1714-1723

  9. CCL2/MCP-1 modulation of microglial activation and proliferation

    Journal of Neuroinflammation, Vol. 8

  10. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: Role of CB2 receptors and iNOS/eNOS

    Diabetes/Metabolism Research and Reviews, Vol. 27, Núm. 4, pp. 331-340

  11. Cannabis, endocannabinoids and neurodevelopment

    Marijuana and Madness: Second Edition (Cambridge University Press), pp. 66-81

  12. Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): Regulation by CB2 receptors and implications for neurotoxicity

    Journal of Neuroinflammation, Vol. 8

  13. Characterization of SMG-9, an essential component of the nonsense-mediated mRNA decay SMG1C complex

    Nucleic Acids Research, Vol. 39, Núm. 1, pp. 347-358

  14. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3- carbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 1, pp. 122-133

  15. Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFκB and iNOS

    Neurochemistry International, Vol. 58, Núm. 6, pp. 676-683

  16. Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: A pilot, randomized controlled trial

    Journal of Health Psychology, Vol. 16, Núm. 5, pp. 770-782

  17. Commentary

    Purinergic Signalling

  18. Comparison of zotarolimus-versus everolimus-eluting stents in the treatment of coronary bifurcation lesions

    Catheterization and Cardiovascular Interventions, Vol. 78, Núm. 7, pp. 1086-1092

  19. Complex Inhibitory Effects of Nitric Oxide on Autophagy

    Molecular Cell, Vol. 43, Núm. 1, pp. 19-32

  20. Conformational selection of the AGA*IA M heparin pentasaccharide when bound to the fibroblast growth factor receptor

    Chemistry - A European Journal, Vol. 17, Núm. 40, pp. 11204-11209